Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCHNASDAQ:DRIONASDAQ:NMTCNASDAQ:POAI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$1.40-1.1%$1.47$1.21▼$7.20$28.34M2.492,724 shs40,453 shsDRIODarioHealth$0.66-5.2%$0.68$0.56▼$1.93$27.59M1.42263,481 shs259,423 shsNMTCNeuroOne Medical Technologies$0.94-3.6%$1.08$0.55▼$1.50$28.86M0.48158,317 shs138,472 shsPOAIPredictive Oncology$1.69+51.6%$1.34$0.55▼$3.06$11.57M1.221.70 million shs153.11 million shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical-1.05%-7.52%-4.39%-9.87%-61.76%DRIODarioHealth+1.73%+2.04%+1.45%+0.01%-51.72%NMTCNeuroOne Medical Technologies-5.83%-10.19%-15.65%+26.01%-17.80%POAIPredictive Oncology+0.90%-3.45%-22.76%+50.13%-58.05%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOCHEnvoy Medical1.5602 of 5 stars3.53.00.00.00.01.70.0DRIODarioHealth3.0092 of 5 stars3.34.00.00.03.20.81.3NMTCNeuroOne Medical Technologies0.061 of 5 stars0.03.00.00.00.00.00.0POAIPredictive Oncology1.9939 of 5 stars3.02.00.00.03.20.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 3.00Buy$8.00471.43% UpsideDRIODarioHealth 2.50Moderate Buy$1.50126.01% UpsideNMTCNeuroOne Medical Technologies 0.00N/AN/AN/APOAIPredictive Oncology 2.00Hold$3.0077.51% UpsideCurrent Analyst Ratings BreakdownLatest POAI, NMTC, DRIO, and COCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/11/2025DRIODarioHealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$3.50 ➝ $2.001/29/2025DRIODarioHealthTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$2.00 ➝ $1.00(Data available from 3/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$278K101.95N/AN/A($0.09) per share-15.56DRIODarioHealth$27.04M1.02N/AN/A$2.14 per share0.31NMTCNeuroOne Medical Technologies$5.75M5.02N/AN/A$0.10 per share9.35POAIPredictive Oncology$1.48M7.80N/AN/A$2.04 per share0.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$29.91MN/A0.00N/AN/A-7,607.55%N/A-262.28%4/7/2025 (Estimated)DRIODarioHealth-$59.43M-$0.62N/AN/AN/A-205.62%-72.16%-40.74%5/13/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.26N/A∞N/A-82.17%-270.70%-129.70%5/12/2025 (Estimated)POAIPredictive Oncology-$13.98M-$3.05N/AN/AN/A-1,012.32%-286.30%-122.11%3/27/2025 (Estimated)Latest POAI, NMTC, DRIO, and COCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/7/2025N/ACOCHEnvoy Medical-$0.33N/AN/AN/AN/AN/A3/27/2025N/ADRIODarioHealth-$0.24N/AN/AN/A$7.39 millionN/A3/27/2025N/APOAIPredictive Oncology-$0.25N/AN/AN/A$0.35 millionN/A2/12/2025Q1 2025NMTCNeuroOne Medical TechnologiesN/A$0.06N/A$0.06N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/ADRIODarioHealthN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/APOAIPredictive OncologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A0.790.61DRIODarioHealth0.351.571.32NMTCNeuroOne Medical TechnologiesN/A3.642.41POAIPredictive OncologyN/A1.201.06Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%DRIODarioHealth33.39%NMTCNeuroOne Medical Technologies16.07%POAIPredictive Oncology9.04%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical60.50%DRIODarioHealth10.90%NMTCNeuroOne Medical Technologies8.90%POAIPredictive Oncology3.44%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3420.25 million8.00 millionNot OptionableDRIODarioHealth20041.57 million28.47 millionOptionableNMTCNeuroOne Medical Technologies2030.86 million28.12 millionOptionablePOAIPredictive Oncology306.85 million6.44 millionNot OptionablePOAI, NMTC, DRIO, and COCH HeadlinesRecent News About These CompaniesTop 8 AI News Updates Driving Markets TodayMarch 25 at 3:31 PM | insidermonkey.comPredictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and OvaryMarch 25 at 7:00 AM | globenewswire.comPredictive Oncology (POAI) to Release Earnings on ThursdayMarch 25 at 2:03 AM | americanbankingnews.comPredictive Oncology completes sale of Skyline Medical assets to DeRoyalMarch 21, 2025 | markets.businessinsider.comPredictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug DiscoveryMarch 20, 2025 | quiverquant.comPredictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal IndustriesMarch 20, 2025 | globenewswire.comPredictive Oncology moves to finalize merger agreement with RenovaroMarch 3, 2025 | markets.businessinsider.comRenovaro completes first milestone payment for Predictive Oncology dealMarch 3, 2025 | markets.businessinsider.comPredictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro BiosciencesMarch 3, 2025 | finance.yahoo.comPredictive Oncology Inc. Completes Registered Direct Offering of 363,336 Shares at $1.50 Per ShareFebruary 19, 2025 | quiverquant.comPredictive Oncology Closes Registered Direct OfferingFebruary 19, 2025 | globenewswire.comPredictive Oncology prices 363,336 shares at $1.50 in registered direct offeringFebruary 19, 2025 | markets.businessinsider.comPredictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq RulesFebruary 19, 2025 | finance.yahoo.comPredictive Oncology (POAI) Struggles AI-Driven Drug Repurposing BreakthroughFebruary 18, 2025 | msn.comPredictive Oncology Inc.: Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug RepurposingFebruary 18, 2025 | finanznachrichten.de2POAI : What's Going On With Predictive Oncology Shares Tuesday?February 18, 2025 | benzinga.comPredictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug RepurposingFebruary 18, 2025 | globenewswire.comCertis Oncology Announces Issuance of U.S. Patent for its Proprietary CertisAI Predictive Oncology Intelligence Platform™February 14, 2025 | biopharmadive.comCertis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ PlatformFebruary 12, 2025 | businesswire.comPredictive partners with Tecan Group for high-throughput drug screeningFebruary 10, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePOAI, NMTC, DRIO, and COCH Company DescriptionsEnvoy Medical NASDAQ:COCH$1.40 -0.02 (-1.06%) Closing price 03:59 PM EasternExtended Trading$1.43 +0.03 (+2.43%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.DarioHealth NASDAQ:DRIO$0.66 -0.04 (-5.19%) Closing price 04:00 PM EasternExtended Trading$0.66 0.00 (-0.71%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.NeuroOne Medical Technologies NASDAQ:NMTC$0.94 -0.04 (-3.61%) Closing price 04:00 PM EasternExtended Trading$0.92 -0.01 (-1.50%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Predictive Oncology NASDAQ:POAI$1.69 +0.58 (+51.57%) Closing price 04:00 PM EasternExtended Trading$1.75 +0.06 (+3.55%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Insiders Sell: This Is What It Means for the Market Oklo’s Stock Price Meltdown Is an Opportunity to Buy Top Dividend Stocks With Over 10 Years of Hikes—and Room to Grow Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage? Will CrowdStrike's FedRAMP Authorization Move CRWD Stock? Top 3 Insider Stock Buys in March—Are They Still Good in April? Taiwan Semiconductor Attracts Big Money on NVIDIA Chip Growth D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
